siRNA therapy lowers triglycerides in individuals with rare problem

.RESEARCH STUDY EMPHASIZE.19 September 2024.

Plozasiran decreased triglyceride amounts through 80% as well as decreased the threat of pancreatitis in individuals with persistent chylomicronemia, with or without a hereditary medical diagnosis.